United States

People: Biogen Inc (BIIB.O)

BIIB.O on Nasdaq

1:12pm EDT
Change (% chg)

$-2.20 (-0.69%)
Prev Close
Day's High
Day's Low
Avg. Vol
52-wk High
52-wk Low

Mulligan, Richard 

Prof. Dr. Richard C. Mulligan, Ph.D. is an Independent Director of the Company. Dr. Mulligan has served as one of our directors since 2009. He is currently a Portfolio Manager at Icahn Capital LP and, since 2013, the Mallinckrodt Professor of Genetics, Emeritus, at Harvard Medical School, after serving as the Mallinckrodt Professor of Genetics and Director of the Harvard Gene Therapy Initiative since 1996. Prior to that, he was Professor of Molecular Biology at the Massachusetts Institute of Technology, a member of the Whitehead Institute for Biomedical Research, and the Chief Scientific Officer of Somatix Therapy Corporation, a drug discovery and development company that he founded. Dr. Mulligan was a founding partner of Sarissa Capital Management LP, an investment firm, from 2013 to 2016. Dr. Mulligan was named a MacArthur Foundation Fellow in 1981.

Basic Compensation

Total Annual Compensation, USD 176,500
Restricted Stock Awards, USD 269,420
Long-Term Incentive Plans, USD --
All Other, USD --
Fiscal Year Total, USD 445,920

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --